Cph Group Ag Class A · SIX:CPHN
Cph Group Ag Class A — CPH Chemie & Papier Holding — Investor Day (September 2022)
30 slides from Cph Group Ag Class A's investor day presentation, Sep 13, 2022
Slide 1: Investors' Day 2022
A Company of CPH Chemie & Papier Holding AG Chemistry Division Investors’ Day 2022 Perlen 13 September 2022 CPH Investors’ Day, 13 September 2022
Slide 2: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 2
Slide 3: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 3
Slide 4: Overview
Overview Market Molecular sieves Specialities Business unit C&E IG Medox TD SZ Gels Deutero Ethanol plants Oxygen Oxygen Air desiccants Odour Agent NMR labs Applications Natural gas generation generation for vehicle elimination separation Pharma: APIs plants brakes and Electronics: windows OLEDs Rüt
Slide 5: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 5
Slide 6: Key success factors
Key success factors Global distribution Production sites in the world’s key regions Focus on innovative and high-value products (Li, binder-free, DMSO, methanol) New applications for Zeochem products (spacers/Purmol, OLED/DMSO) generating sales in new markets Market share gained from competitors thr
Slide 7: Zeochem's global presence 2014
Zeochem’s global presence 2014 Zeochem Uetikon (Switzerland) Zeochem Louisville (USA) Zeochem LLC Houston (USA) Production site and distribution centre Distribution centre Distribution personnel Americas Europe Middle Southeast Rest of Total East Asia Asia 9 7 0 0 0 16 CPH Investors’ Day, 13 Septemb
Slide 8: Zeochem's global presence 2022
Zeochem’s global presence 2022 Zeochem Zeochem (Belgium) (Czech Republic) Zeochem Zeochem Rüti Zeochem Zeochem Louisville (USA) (Switzerland) Zvornik (BIH) Donghai (China) Zeochem (Japan) Zeochem Zeochem Houston (USA) Shanghai (China) Zeochem Aquachemie (Bahrain) Zeochem Singapore Zeochem (Brazil) P
Slide 9: Focused channel management
Focused channel management Rüti Tokyo Shanghai Louisville Bahrain Singapore Medox (direct) IG (direct) São Paulo C&E TED SZ Gels Deutero (NMR) -> laboratory equipment distributors CPH Investors’ Day, 13 September 2022 Zeochem Sales Hub 9 Distribution Partner
Slide 10: Strategic realignment since 2014
Strategic realignment since 2014 100 Donghai Small automated line Donghai Deduster 80 Louisville Li Products Expansion Zvornik Purmol Expansion Rüti Re-Enrichment Column 60 Louisville New Admin Building Sales Rep in ME, Japan, Brazil, Czeck Rep. Net sales Shanghai Yusheng 40 Acquisition of Armar Shu
Slide 11: CPH strategy as applied to the Chemistry Division
CPH strategy as applied to the Chemistry Division Tangible increases in Zeochem’s net sales in 2021 and 2022 bringing better balance to divisional shares of CPH’s total net sales. Development of new markets in Asia and in North and South America increasing proportion of group net sales generated out
Slide 12: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 12
Slide 13: Megatrends
Megatrends Trend Description Zeochem and the trend Healthcare The health of the world’s - Zeochem manufactures high- Energy population is improving performance molecular sieves for globally at different speeds. the production of medical oxygen. Mobility Most countries’ healthcare - Zeochem’s chromat
Slide 14: Megatrends
Megatrends Trend Description Zeochem and the trend Healthcare Energy is indispensable to the - Zeochem’s molecular sieves are Energy global economy. The switch used in the purification of natural from fossil to sustainable gas. Natural gas is regarded as an Mobility energy sources has begun. interim
Slide 15: Megatrends
Megatrends Trend Description Zeochem and the trend Healthcare The mobility megatrend - Zeochem manufactures products Energy describes the rise of a global that are used in vehicle braking mobile culture, changes systems. Mobility through new products and - Zeochem’s products are used to services and
Slide 16: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 16
Slide 17: Business development
Business development CHF million % 100 +8% p.a. 50 • Swiss franc strengthened around -2% p.a. 80 40 40% against the euro between 2009 60 30 and 2015 (from EUR 1.00 = CHF 40 16.1% 20 1.50 to EUR 1.00 = CHF 1.05); 2.3% 5.1% 7.7% 5.6% 6.3% pressure on net sales and earnings 20 -13.8% -6.6% -3.6% 0.0% 1
Slide 18: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 18
Slide 19: Innovation: The Superspacer
Innovation: The Superspacer A more energy-efficient way to manufacture non-fogging double glazing CPH Investors’ Day, 13 September 2022 19
Slide 20: Innovation: dosing medications
Innovation: dosing medications Substituting H20 with D20 in medications (APIs) ensures that the active ingredients remain longer in the human body, which in turn helps optimize the dosages required. Approved by the FDA for the treatment of tardive dyskinesia and Huntington’s in 2019 CPH Investors’ D
Slide 21: Agenda
Agenda Overview Strategic realignment since 2014 Megatrends Business development Innovation Outlook CPH Investors’ Day, 13 September 2022 21
Slide 22: Outlook: ongoing investment projects make Zeochem fit for the future
Outlook: ongoing investment projects make Zeochem fit for the future Trend Healthcare, energy Healthcare Mobility Healthcare Zeochem Zeochem Zeochem Zeochem Louisville (USA) Rüti (Switzerland) Zvornik (Bosnia and Herzegovina) Donghai (China) • Expansion of Li • Expansion of DMSO • Expansion of Purmo
Slide 23: Outlook by business unit
Outlook by business unit Market Molecular sieves Specialities Business unit C&E IG Medox TD SZ Gels Deutero Steep Oxygen Short-term Air braking Continuous Continuous Strong growth Outlook increase in generation for post-COVID systems and steady further steady further in the OLED, demand for steel an
Slide 24: Outlook: in summary
Outlook: in summary 2022 Double-digit net sales growth expected Additional US capacities will come into operation Raw materials and transport costs will continue to rise Operating margin likely to fall somewhat short of its high 2021 level For 2022 we expect to see higher net sales and pressure on
Slide 25: Innovation: The Superspacer
Innovation: The Superspacer A more energy-efficient way to manufacture non-fogging double glazing CPH Investors’ Day, 13 September 2022 25
Slide 26: Innovation: dosing medications
Innovation: dosing medications Substituting H20 with D20 in medications (APIs) ensures that the active ingredients remain longer in the human body, which in turn helps optimize the dosages required. Approved by the FDA for the treatment of tardive dyskinesia and Huntington’s in 2019 CPH Investors’ D
Slide 27: Agenda
Agenda • Overview • Strategic realignment since 2014 • Megatrends • Business development • Innovation • Outlook CPH Investors’ Day, 13 September 2022 27
Slide 28: Outlook: ongoing investment projects make Zeochem fit for the future
Outlook: ongoing investment projects make Zeochem fit for the future Trend Healthcare, energy Healthcare Mobility Healthcare Zeochem Zeochem Zeochem Zeochem Louisville (USA) Rüti (Switzerland) Zvornik (Bosnia and Herzegovina) Donghai (China) • Expansion of Li • Expansion of DMSO • Expansion of Purmo
Slide 29: Outlook by business unit
Outlook by business unit Market Molecular sieves Specialities Business unit C&E IG Medox TD SZ Gels Deutero Steep Oxygen Short-term Air braking Continuous Continuous Strong growth Outlook increase in generation for post-COVID systems and steady further steady further in the OLED, demand for steel an
Slide 30: Outlook: in summary
Outlook: in summary 2022 • Double-digit net sales growth expected • Additional US capacities will come into operation • Raw materials and transport costs will continue to rise • Operating margin likely to fall somewhat short of its high 2021 level For 2022 we expect to see higher net sales and pre
CPH Chemie & Papier Holding — Investor Day (September 2022) on 6ix